No abstract available
MeSH terms
-
Antibodies, Monoclonal / economics
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antilymphocyte Serum / economics
-
Antilymphocyte Serum / therapeutic use
-
Basiliximab
-
Cost-Benefit Analysis*
-
Daclizumab
-
Graft Rejection / drug therapy
-
Graft Survival
-
Humans
-
Immunoglobulin G / economics
-
Immunoglobulin G / therapeutic use
-
Immunosuppressive Agents / economics*
-
Immunosuppressive Agents / therapeutic use
-
Kidney Transplantation / economics*
-
Mycophenolic Acid / analogs & derivatives
-
Mycophenolic Acid / economics
-
Mycophenolic Acid / therapeutic use
-
Recombinant Fusion Proteins*
-
Renal Dialysis / economics
-
Retrospective Studies
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antilymphocyte Serum
-
Immunoglobulin G
-
Immunosuppressive Agents
-
Recombinant Fusion Proteins
-
Basiliximab
-
Daclizumab
-
Mycophenolic Acid